Nordson Corporation · NASDAQ:NDSN

Nordson — Investor Presentation (February 2025)

37 slides from Nordson's investor presentation, Feb 20, 2025

  1. Slide 1: Investor Presentation

    Investor Presentation February 20, 2025 Nasdaq: NDSN NBS NEXT OWNER MINDSET WINNING TEAMS

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by

  3. Slide 3: Nordson is a growth compounder with unique competitive advantages

    Nordson is a growth compounder with unique competitive advantages Company Founded 2024 Revenue 2024 EBITDA% Employees Countries with Direct Presence 1954 $2.7B 32% 8,000+ 35+ 3

  4. Slide 4: By the Numbers

    By the Numbers Demonstrated Consistent Record Disciplined focus Differentiated Consistent value to Value to Solid Returns of Growth on profitability Product Portfolio* shareholders Customers 6% 55% 30% 13% 2,100+ 61 yrs. Sales Growth Gross Margins EBITDA Margins Global Patents of Annual ROIC Held Di

  5. Slide 5: Commitment to ESG

    Commitment to ESG Diversified Board of Directors Strong Culture and Values Environmental Stewardship  50% diverse board (3 gender and 2  Nordson Impact – Invest 5% of domestic  Product design improvements focused on racially or ethnically diverse) pretax earnings in communities reducing customers

  6. Slide 6: Diversified Sources of Sales

    Diversified Sources of Sales FY2024 Profile - $2.7 Billion Product Type Geographies 29% Parts and Americas 43% Consumables 44% Europe 57% Systems Asia Pacific 27% High percentage of recurring Diversified geographic footprint. sales from parts and Direct presence in over consumables. 35 countries. 6

  7. Slide 7: Diversified End Markets

    Diversified End Markets Consumer Non-Durable Electronics Medical Industrial Remaining Markets 25% of revenue 23% of revenue 21% of revenue 19% of revenue 12% of revenue  Box sealing  Semiconductor packaging  Balloons, extrusions, delivery  Construction and industrial  Consumer durable catheters

  8. Slide 8: How We Are Organized

    How We Are Organized INDUSTRIAL PRECISION SOLUTIONS MEDICAL FLUID SOLUTIONS ADVANCED TECHNOLOGY SOLUTIONS Adhesives, Industrial Coatings, Interventional Solutions, Fluid Components Electronic Processing Systems Measurement and Control Solutions & Polymer Processing Systems & Engineered Fluid Dispens

  9. Slide 9: Industrial Precision Solutions

    Industrial What We Do Product lines reduce material consumption, Precision increase line efficiency, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, Solutions sealants and other materials. This business primarily serves the industria

  10. Slide 10: Medical Fluid Solutions

    Medical What We Do Fluid management solutions for medical, high- Fluid tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips, and fluid connection Solutions components are used to dispense or control fluids within customers’ medical de

  11. Slide 11: Advanced Technology Solutions

    Advanced What We Do Design and develop proprietary technologies found Technology in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test, Solutions inspection and measurement to ensure quality and reliab

  12. Slide 12: Why Invest in Nordson?

    CNordson Why Invest in Nordson?

  13. Slide 13: A Growth Portfolio Ready to Accelerate

    A Growth Portfolio Ready to Accelerate 2014 (FY Revenue $1.7B) 2024 (FY Revenue $2.7B) 39% Systems 43% Systems Parts / Service 57% Parts / Service 61% Growth Growth 29% End Markets 44% End Markets 12% 23% 23% 24% Electronics 19% 6% Medical 5% 21% Nondurables 42% Industrial 25% 13 Other

  14. Slide 14: 2025-2029 Financial Targets

    2025-2029 Financial Targets Growth Compounder Revenue Adjusted EPS Growth Growth 6-8% 10-12% Average annual growth Engaged Employees Driven by Nordson Values 14

  15. Slide 15: Driving profitable growth by investing in the best growth opportunities

    Driving profitable growth by selecting and investing disproportionately in the 15 best growth opportunities

  16. Slide 16: Entrepreneurial division-led organization

    Entrepreneurial division-led organization:  Decisions close to the customer  Autonomy + Accountability  Clear line of sight to deploying NBS Next 16

  17. Slide 17: Key ingredient to successful execution of the Ascend strategy

    A key ingredient to successful execution of the Ascend strategy:  Leaders inspiring trust and building followership in the organization  Focus on inclusion and diversity in everything we do  Create an engaging culture that attracts and retains top talent 17

  18. Slide 18: Disciplined Approach to M&A

    Disciplined Approach to M&A  Strategic Criteria Financial Criteria  Serving attractive end market niches and  Growth at or above market rates with Nordson- applications like gross margins  Differentiated product technologies/solutions  EBITDA ~20+% with margin expansion opportunities  Additive

  19. Slide 19: Growth Algorithm

    Growth Algorithm Revenue Adjusted EPS 3% - 4% 4% 6%-8% $2.7B 3% - 4% 10%-12% $9.73 6% - 8% 2024 Organic M&A 2029 2024 Incremental Profit NBS Next 2029 19

  20. Slide 20: Superior Conversion / Deployment of Cash Flows

    Superior Conversion / Deployment of Cash Flows Generation of ~ $4.1B in operating cash flows through 2029 Capital Deployment through 2029 Cash Flow Deployment Priorities  Fund organic growth 7%  Return to shareholders thru dividends and Organic Capital routine stock repurchases to offset dilution

  21. Slide 21: Recent Financial Results

    CNorison Recent malatclalerts) Results

  22. Slide 22: Total Company – 1Q 2025

    Total Company – 1Q 2025 1Q 2025 Sales Bridge** Sales $633 $53  Reported sales of $615M, a decrease of 3%, at the $615 low end of prior guidance range $(11) $(59)  8% growth from the Atrion acquisition; unfavorable currency impact of 2%  9% organic decrease driven by weakness in polymer processing

  23. Slide 23: Balance Sheet and Cash Flow

    Balance Sheet and Cash Flow Balanced Capital Deployment Returning Value to Shareholders Net Debt Free Cash Flow*  Cash totaled $130 million  Cash flow of $138 million, which is a conversion rate of 146% of net income, deployed toward:  2.4x net debt leverage ratio based on trailing 12-month o Sha

  24. Slide 24: 2Q Fiscal 2025 Guidance

    2Q Fiscal 2025 Guidance 2Q 2025 Sales Guidance $650 - $690 Steady performance moving into 2Q $650 $651  Historical seasonality and order entry trends support moderate increases in sales and earnings sequentially  Backlog grew by ~$85 million or 15% in the first quarter, ending at approximately $67

  25. Slide 25: 2025 Fiscal Full-Year Guidance

    2025 Fiscal Full-Year Guidance Full-year Sales Guidance Full-Year Growth from Record 2024 $2,750 - $2,870  Ascend strategy is advancing and delivering results  Backlog, including Atrion, is ~$670 million as of 1/31/25 $2,689 $2,629  Fiscal 2025 sales growth of 2% to 7%, inclusive of FX headwind o

  26. Slide 26: Appendix 1: Product Innovation

    Appendix 1: Product Innovation

  27. Slide 27: Our Electronics Industry Position

    Our Electronics Industry Position Surface Mount Manufacturing Solder paste Flux spray Optical Inline Systems Plasma Underfill, Optical X-ray Conformal inspection coating inspection surface encapsulation inspection inspection coating treatment or precise coating Solder paste Component placement Reflo

  28. Slide 28: Our Role in the Semiconductor Process

    Our Role in the Semiconductor Process 28

  29. Slide 29: CyberOptics expands market opportunities

    CyberOptics expands market opportunities Nordson T&I Division CyberOptics Optical Sensors & Systems 3D Optical semi market expected to grow ~15%+, 29 exceeding the broader ‘Wafer Fab Equipment’ market LSD ’23 – ’25 growth

  30. Slide 30: Medical and Fluid Solutions

    Medical and Fluid Solutions Fluid Solutions Interventional Solutions Fluid Components Precision Low-Volume Dispensing Medical balloons, catheters, cannulas Single-use components From benchtop dispensers to industry-best From specialty tubing, catheters, medical Proprietary single-use plastic jetting

  31. Slide 31: Core Adhesives Innovative Technology

    Core Adhesives Innovative Technology Auto-fill Tankless Variable Dispense Foaming Jetting Precision dispense Technology Technology Technology Technology technology Adhesive fill systems Delivering different Maintains bond strength Dispenses adhesive Increases production monitor and maintain add-on r

  32. Slide 32: Appendix 2: Financial Exhibits

    Appendix 2: Financial Exhibits

  33. Slide 33: Non-GAAP Definitions

    Appendix Non-GAAP Definitions This presentation contains references to non-GAAP financial information. Although these are non-GAAP measures, we believe that they are useful to an investor in evaluating the company performance for the period presented. These non-GAAP definitions include:  EBITDA is

  34. Slide 34: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Net Income to Adjusted EBITDA (Dollars in thousands) 34

  35. Slide 35: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 35

  36. Slide 36: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 36

  37. Slide 37: Reconciliation of Non-GAAP Measures

    Reconciliation of Non-GAAP Measures Operating Cash Flow to Free Cash Flow 37

Nordson — Investor Presentation (February 2025) on 6ix